{
  "@context": "http://id.who.int/icd/contexts/contextForLinearizationEntity.json",
  "@id": "http://id.who.int/icd/release/11/2024-01/mms/1581599493",
  "parent": [
    "http://id.who.int/icd/release/11/2024-01/mms/1738843761"
  ],
  "browserUrl": "https://icd.who.int/browse/2024-01/mms/en#1581599493",
  "code": "2A60.20",
  "source": "http://id.who.int/icd/entity/1581599493",
  "classKind": "category",
  "postcoordinationScale": [
    {
      "@id": "http://id.who.int/icd/release/11/2024-01/mms/1581599493/postcoordinationScale/histopathology",
      "axisName": "http://id.who.int/icd/schema/histopathology",
      "requiredPostcoordination": "false",
      "allowMultipleValues": "NotAllowed",
      "scaleEntity": [
        "http://id.who.int/icd/release/11/2024-01/mms/1073612076",
        "http://id.who.int/icd/release/11/2024-01/mms/1535830689"
      ]
    },
    {
      "@id": "http://id.who.int/icd/release/11/2024-01/mms/1581599493/postcoordinationScale/hasManifestation",
      "axisName": "http://id.who.int/icd/schema/hasManifestation",
      "requiredPostcoordination": "false",
      "allowMultipleValues": "AllowAlways",
      "scaleEntity": [
        "http://id.who.int/icd/release/11/2024-01/mms/322466810"
      ]
    }
  ],
  "title": {
    "@language": "en",
    "@value": "Therapy related acute myeloid leukaemia or myelodysplastic syndrome"
  },
  "indexTerm": [
    {
      "label": {
        "@language": "en",
        "@value": "Therapy related acute myeloid leukaemia or myelodysplastic syndrome"
      }
    },
    {
      "label": {
        "@language": "en",
        "@value": "Acute myeloid leukemia and myelodysplastic syndromes related to alkylating agent"
      },
      "foundationReference": "http://id.who.int/icd/entity/1401970160"
    },
    {
      "label": {
        "@language": "en",
        "@value": "Acute myeloid leukemia and myelodysplastic syndromes related to topoisomerase type 2 inhibitor"
      },
      "foundationReference": "http://id.who.int/icd/entity/88207494"
    }
  ]
}